Advertisement

Topics

Karius, Inc. Company Profile

03:59 EDT 19th June 2019 | BioPortfolio

Karius is a life sciences company focused on conquering infectious diseases through the innovative use of next-generation sequencing to analyze microbial cell-free DNA. The company’s genomics platform delivers unprecedented insight into the microbial landscape, providing clinicians with a comprehensive test capable of identifying more than a thousand pathogens directly from blood and helping industry accelerate drug development. For more information visit kariusdx.com and follow us on Twitter at @kariusdx.


News Articles [6 Associated News Articles listed on BioPortfolio]

Karius secures $25mm in debt financing from Oxford Finance

Oxford Finance provided Karius Inc. (infectious disease diagnostics) with a $25mm senior secured term loan. Karius will use the proceeds to bring its Karius next-generation sequencing test to more hos...

Newly Published Case Series Demonstrates the Karius Test’s Effectiveness for Monitoring Infections in Stem-Cell Transplant Patients at Risk of Infections

REDWOOD CITY, Calif. (PRWEB) December 13, 2018 Karius , Inc., a life sciences company transforming infectious disease diagnostics w...

Precision Medicine Looks beyond DNA Sequences — Good report by @julemieux1 featuring @PhaseGenomics @lexentbio @MissionBio, Karius, @job_dekker @JShendure https://www.genengnews.com/magazine/november-15-2018-vol-38-no-20/precision-medicine-looks-beyon

Precision Medicine Looks beyond DNA Sequences — Good report by @julemieux1 featuring @PhaseGenomics @lexentbio @MissionBio, Karius, @job_dekker @JShendure

Newly Published Case Series Demonstrates the Karius Test’s Effectiveness for Monitoring Infections in Stem-Cell Transplant Patients at Risk of Infections

Karius and Clinical Investigators from UCSF Showed that the Karius Test can Quickly and Accurately Detect Infections Earlier than Standard Diagnostics in Immunocompromised Patients REDWOOD CITY, Calif...

Slone Partners, Where People Are Our Science®, Places Michael Mercer as Chief Commercial Officer at Karius

Mr. Mercer brings over 25 years of exceptional scientific healthcare leadership experience SAN FRANCISCO (PRWEB) December 04, 2018 Slone Partners, North America’s leading executive search firm for ...

Is There a Diagnostic Company to Rise From the Ashes of Theranos?

Companies are filling in the gaps and the entire area of so-called “liquid biopsies” is hot these days, with companies like Guardant Health, Karius, Freenome, Apostle and GRAIL Bio entering the ma...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [6 Associated Clinical Trials listed on BioPortfolio]

Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal Infections

The purpose of this study is to evaluate the use of a blood test: Karius® plasma-based next-generation sequencing test (Karius Test), to see if we can detect and measure the infection cau...

Diagnosis of Bacteremia/Septicemia by the Karius Sequencing-Based Infectious Disease Diagnostic Assay

Prospective study at Duke University Hospital comparing the Karius Infectious Disease Diagnostic Sequencing Assay to blood culture results in admitted patients with bacteremia/septicemia.

SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay

The purpose of this study is to evaluate the performance of the Karius Infectious Diseases Plasma Sequencing Assay in patients who present to the emergency room with sepsis.

The DISCOVER Trial (Diagnosis of Infection in Stem Cell Transplant Patients OVER Time)

Demonstrate that the Karius Infectious Disease Diagnostic Sequencing Assay performed on plasma can accurately detect the microbiologic etiology in febrile allogeneic stem-cell transplant p...

Detection of Dengue Virus in Plasma of Patients in Nepal

To test whether Karius Infectious Disease Diagnostic Sequencing assay can detect Dengue Virus in plasma from suspected cases of Dengue or Dengue Fever like-illnesses from samples collected...

Companies [1 Associated Companies listed on BioPortfolio]

Karius, Inc.

Karius is a life sciences company focused on conquering infectious diseases through the innovative use of next-generation sequencing to analyze microbial cell-free DNA. The compan...

More Information about "Karius, Inc." on BioPortfolio

We have published hundreds of Karius, Inc. news stories on BioPortfolio along with dozens of Karius, Inc. Clinical Trials and PubMed Articles about Karius, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Karius, Inc. Companies in our database. You can also find out about relevant Karius, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...


Corporate Database Quicklinks



Searches Linking to this Company Record